Skip to main content

Table 1 Clinical characteristics

From: Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses

  Controls
(n = 15)
CAD
(n = 15)
Age (years) 58.86 ± 2.19 61.58 ± 2.60
Sex (M/F) 11/4 10/5
BMI (kg/m2) 25.69 ± 1.01 29.66 ± 1.28*
Statin use, n (%) 3 (20%) 3 (20%)
Anti-hypertensive agents, n (%) 10 (67%) 9 (60%)
Anti-platelet agents, n (%) 2 (13%) 4 (27%)
Anti- diabetic agents, n (%) 4 (27%) 6 (40%)
Organic Nitrates, n (%) 2 (13%) 3 (20%)
Aspirin, n (%) 5 (33%) 6 (40%)
DM2, n (%) 6 (40%) 8 (53%)
Active smokers, n (%) 3 (20%) 2 (13%)
SBP (mmHg) 122.93 ± 4.26 127.50 ± 5.38
DBP (mmHg) 73.93 ± 3.79 75.33 ± 3.99
Creatinine (mg/dL) 0.86 ± 0.06 0.87 ± 0.07
eGFR (mL/min/1.73 m2) 60.00 ± 0.01 59.80 ± 0.20
TSH (mIU/L) 2.42 ± 0.52 3.33 ± 0.45
T4 (μg/dL) 8.12 ± 0.86 8.12 ± 0.45
T3 (ng/mL) 1.16 ± 0.04 1.14 ± 0.02
Cholesterol (mg/dL) 147.82 ± 13.28 103.08 ± 14.73*
Triglycerides (mg/dL) 99.09 ± 6.49 100.40 ± 6.49
Glucose (mg/dL) 92.84 ± 2.55 106.21 ± 6.19*
HDL-cholesterol (mg/dL) 40.67 ± 3.20 31.32 ± 2.17*
 Free HDL-cholesterol (mg/dL) 10.36 ± 1.71 11.77 ± 1.04
 Esterified HDL-cholesterol (mg/dL) 50.91 ± 5.37 32.84 ± 4.54*
HDL- triglycerides (mg/dL) 29.63 ± 3.13 24.78 ± 1.99
HDL-phospholipids (mg/dL) 70.31 ± 5.04 70.41 ± 5.33
LDL-cholesterol (mg/dL) 98.18 ± 6.65 62.51 ± 4.70*
HDL 2b (%) 17.59 ± 0.82 20.83 ± 1.90
HDL 2a (%) 11.40 ± 0.30 12.25 ± 0.46
HDL 3a (%) 26.82 ± 1.03 27.05 ± 0.40
HDL 3b (%) 18.69 ± 0.40 20.29 ± 0.61*
HDL 3c (%) 24.49 ± 1.31 20.22 ± 1.44*
SYNTAX score 0.00 (0.00–0.00) 10.00 (2.00–44.00)
  1. CAD coronary artery disease; BMI body mass index; DM2 type 2 diabetes mellitus; SBP systolic blood pressure; HDL high density lipoprotein; LDL low density lipoprotein; M male; female; eGFR estimated glomerular filtration rate; TSH thyroid stimulating hormone; T4 thyroxine; T3 triiodothyronine
  2. Data are shown as mean ± SE. Student’s t test *p < 0.05 vs. control group